Misonix Reports Third Quarter Fiscal Year 2017 Financial Results
May 02, 2017 20:02 pm UTC| Business
FARMINGDALE, N.Y., May 02, 2017 -- Misonix, Inc. (Nasdaq:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today financial results for the three and...
T2 Biosystems Reports First Quarter 2017 Results and Corporate Update
May 02, 2017 20:02 pm UTC| Business
LEXINGTON, Mass., May 02, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced operating highlights and financial results for the first quarter ended March 31, 2017. Recent Operational and First Quarter...
T2 Biosystems Reports First Quarter 2017 Results and Corporate Update
May 02, 2017 20:02 pm UTC| Business
LEXINGTON, Mass., May 02, 2017 -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced operating highlights and financial results for the first quarter ended March 31, 2017. Recent Operational and First Quarter...
May 02, 2017 20:02 pm UTC| Business
SALT LAKE CITY, May 02, 2017 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, today announced financial results for the first quarter ending March 31, 2017. First Quarter Highlights (Comparisons...
May 02, 2017 20:02 pm UTC| Business
SALT LAKE CITY, May 02, 2017 -- ZAGG Inc (Nasdaq:ZAGG), a leading global mobile lifestyle company, today announced financial results for the first quarter ending March 31, 2017. First Quarter Highlights (Comparisons...
Amicus Therapeutics to Announce First Quarter 2017 Financial Results on May 9, 2017
May 02, 2017 20:01 pm UTC| Business
CRANBURY, N.J., May 02, 2017 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of rare and orphan diseases, today announced a conference call and live audio webcast on Tuesday, May 9,...
Vital Therapies Announces Upcoming First Quarter Financial Results Conference Call With Webcast
May 02, 2017 20:01 pm UTC| Business
SAN DIEGO, May 02, 2017 -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its first quarter 2017...